Clinical Trial Update: Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs [NA]

View source ↗

Summary

A clinical trial update examining how magnesium variations relate to cardiometabolic risk in patients taking antipsychotic medications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Magnesium (magnesium)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: UNKNOWN